Artemis Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 70,000 compared to USD 212,000 a year ago. Net loss was USD 69,000 compared to USD 141,000 a year ago. Basic loss per share was USD 0.01 compared to USD 0.02 a year ago. For the half year, operating loss was USD 90,000 compared to USD 512,000 a year ago. Net loss was USD 90,000 compared to USD 352,000 a year ago. Basic loss per share was USD 0.01 compared to USD 0.06 a year ago.